{"id":70740,"date":"2026-05-12T10:25:30","date_gmt":"2026-05-12T10:25:30","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70740"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"ghrp-2","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-br\/product\/ghrp-2\/","title":{"rendered":"Acetato de GHRP-2"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 Acetato de GHRP-2?<\/h3>\n<p style=\"margin: 0;\"><strong>Acetato de GHRP-2<\/strong> (tamb\u00e9m chamado de Pralmorelin ou KP-102) \u00e9 um hexapept\u00eddeo sint\u00e9tico secretagogo de horm\u00f4nio do crescimento com 6 amino\u00e1cidos e o membro mais potente da primeira gera\u00e7\u00e3o da s\u00e9rie GHRP por mg. Ele atua no receptor secretagogo de horm\u00f4nio do crescimento (GHS-R1a) \u2014 o mesmo receptor da grelina end\u00f3gena e do <a href=\"https:\/\/medsbase.com\/pt-br\/ghrp-6\/\">GHRP-6<\/a> \u2014 producing pulsatile GH release with a smaller appetite signal than GHRP-6 but a similar cortisol\/prolactin profile. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que voc\u00ea obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Todo pedido \u00e9 coberto pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Reenvio Garantido<\/strong><\/a> \u2014 se sua encomenda n\u00e3o chegar em 20 dias \u00fateis, n\u00f3s a reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">158861-67-7 (base livre do GHRP-2); fornecido na forma de sal de acetato<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>45<\/sub>H<sub>55<\/sub>N<sub>9<\/sub>O<sub>6<\/sub> (base livre; sal de acetato adiciona contra\u00edon CH<sub>3<\/sub>COOH)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">817.97 Da (base livre)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH<sub>2<\/sub> (6 amino\u00e1cidos; cont\u00e9m D-Ala na posi\u00e7\u00e3o 1, D-2-naftilalanina na posi\u00e7\u00e3o 2 e D-Phe na posi\u00e7\u00e3o 5 para estabilidade proteol\u00edtica; C-terminalmente amidado). Tamb\u00e9m conhecido como Pralmorelin \/ KP-102.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Sal de acetato liofilizado (p\u00f3 branco a branco-acinzentado)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA sob solicita\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (geladeira) para estoque de trabalho; \u221220 \u00b0C para armazenamento de longo prazo de frascos fechados. Reconstitu\u00eddo: 2\u20138 \u00b0C, usar em at\u00e9 ~30 dias. Proteger da luz. N\u00e3o congelar e descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de uso mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 GHRP-2 Acetato?<\/h2>\n<p><strong>GHRP-2<\/strong> (Pept\u00eddeo Liberador de Horm\u00f4nio do Crescimento 2), tamb\u00e9m conhecido como <strong>Pralmorelin<\/strong> ou pelo seu c\u00f3digo de desenvolvimento original <strong>KP-102<\/strong>, is a 6-amino-acid synthetic hexapeptide and one of the canonical first-generation members of the growth hormone secretagogue (GHS) peptide class. It was developed shortly after GHRP-6 in the same Bowers structure-activity-relationship programme at Tulane University, with a focus on increasing per-mg potency relative to the parent compound while preserving the GHS-R1a-selective receptor profile. The acetate counterion is used in pharmaceutical-grade lyophilization because it improves long-term peptide stability and aqueous solubility without altering pharmacology. The well-characterised sequence is D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH<sub>2<\/sub>, peso molecular 817,97\u00a0Da, f\u00f3rmula emp\u00edrica C<sub>45<\/sub>H<sub>55<\/sub>N<sub>9<\/sub>O<sub>6<\/sub>. The structural innovation relative to GHRP-6 is the introduction of D-2-naphthylalanine (D-2-Nal) at position 2 in place of D-Trp \u2014 the more lipophilic naphthyl ring increases GHS-R1a affinity and produces approximately 2\u20133-fold greater per-mg GH-releasing potency in published studies. The two D-amino-acid substitutions (D-Ala at position 1, D-Phe at position 5) confer protease resistance. Notably, in Japan GHRP-2 (under the name Pralmorelin Hydrochloride \/ GHRP Kaken) was approved as a single-use intravenous diagnostic agent for adult growth hormone deficiency testing \u2014 one of the only GHS peptides to reach any form of clinical approval. GHRP-2 remains <strong>n\u00e3o aprovado<\/strong> by the FDA, EMA, MHRA, or any other Western regulator for therapeutic use. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Agonismo do Receptor GHS-R1a com Pot\u00eancia Aprimorada<\/h2>\n<p>O que torna o GHRP-2 mecanicamente distinto entre os secretagogos de horm\u00f4nio do crescimento de primeira gera\u00e7\u00e3o \u00e9 a combina\u00e7\u00e3o de <strong>alta afinidade pelo GHS-R1a com uma meia-vida plasm\u00e1tica relativamente curta<\/strong>, producing a sharper and more reproducible GH pulse in published studies:<\/p>\n<ul>\n<li><strong>Agonismo do receptor GHS-R1a em somatotrofos<\/strong> \u2014 O GHRP-2 se liga ao receptor secretagogo de horm\u00f4nio do crescimento tipo 1a (GHS-R1a, o receptor da grelina) nos somatotr\u00f3ficos da hip\u00f3fise anterior. A ativa\u00e7\u00e3o do receptor acopla-se \u00e0 G\u03b1<sub>q\/11<\/sub> e \u00e0 fosfolipase C, elevando o c\u00e1lcio intracelular e desencadeando a exocitose de ves\u00edculas contendo GH. A substitui\u00e7\u00e3o de D-2-Nal na posi\u00e7\u00e3o 2 produz aproximadamente 2\u20133 vezes maior ocupa\u00e7\u00e3o do receptor em doses equivalentes em compara\u00e7\u00e3o com o GHRP-6 em ensaios de liga\u00e7\u00e3o de radioligantes, traduzindo-se em um pulso de GH maior por unidade de dose.<\/li>\n<li><strong>Supress\u00e3o do t\u00f4nus de somatostatina<\/strong> \u2014 Como outros GHRPs, o GHRP-2 atua tanto no somatotr\u00f3fico quanto nos neur\u00f4nios hipotal\u00e2micos que liberam somatostatina. Ao suprimir a inibi\u00e7\u00e3o t\u00f4nica da somatostatina simultaneamente com a estimula\u00e7\u00e3o da libera\u00e7\u00e3o do somatotr\u00f3fico, o pept\u00eddeo produz um pulso de GH l\u00edquido maior do que a estimula\u00e7\u00e3o direta da hip\u00f3fise sozinha preveria. Essa a\u00e7\u00e3o dupla \u00e9 o mecanismo can\u00f4nico da classe GHRP e fundamenta a sinergia com os an\u00e1logos de GHRH descritos abaixo.<\/li>\n<li><strong>Sinergia com agonistas do receptor GHRH<\/strong> \u2014 As vias GHS-R e GHRH-R convergem intracelularmente, mas utilizam sistemas de segundos mensageiros diferentes (PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> vs adenylyl cyclase\/cAMP\/PKA), so GHRP-2 and GHRH analogs produce additive or synergistic GH release when combined. The canonical protocol pairs GHRP-2 with a GHRH analog such as <a href=\"https:\/\/medsbase.com\/pt-br\/sermorelin\/\">Sermorelina<\/a> ou <a href=\"https:\/\/medsbase.com\/pt-br\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> for maximal pulsatile GH studies stimulus. The &#8220;GHRP-2 + GHRH&#8221; challenge is also the basis for the Japanese clinical use of Pralmorelin in GH-deficiency diagnostic testing.<\/li>\n<\/ul>\n<p>GHRP-2 produces a smaller appetite signal than GHRP-6 in head-to-head rodent and human studies \u2014 the D-2-Nal substitution at position 2 reduces but does not eliminate the orexigenic activity inherited from ghrelin-receptor agonism. The cortisol and prolactin signals remain present at levels comparable to GHRP-6, which is the principal studies-relevant confound that newer receptor-selective analogs (Ipamorelin) were designed to eliminate. Plasma half-life is approximately 15\u201320 minutes \u2014 shorter than GHRP-6 (~30\u201360 min) \u2014 which produces a sharper and more reproducible GH pulse but requires more frequent dosing for sustained-stimulus protocols. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GHRP-2 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Farmacologia do eixo do horm\u00f4nio do crescimento<\/strong> \u2014 din\u00e2mica puls\u00e1til de GH, dose-resposta do somatotr\u00f3fico, ensaios comparativos de pot\u00eancia de GHS; refer\u00eancia de GHS de alta pot\u00eancia de primeira gera\u00e7\u00e3o na literatura publicada sobre o eixo GH (Bowers, J Clin Endocrinol Metab; Ghigo et al., J Clin Endocrinol Metab)<\/li>\n<li><strong>GH-deficiency diagnostic studies<\/strong> \u2014 Teste de estimula\u00e7\u00e3o com GHRP-2 para defici\u00eancia de GH em adultos (caso cl\u00ednico japon\u00eas), teste combinado GHRP-2 + GHRH, caracteriza\u00e7\u00e3o da reserva somatotr\u00f3fica em modelos pr\u00e9-cl\u00ednicos<\/li>\n<li><strong>Pituitary function studies<\/strong> \u2014 GH reserve testing, somatotroph hypertrophy \/ hyperplasia, mechanism-of-action data for novel GH secretagogues<\/li>\n<li><strong>Cachexia and wasting syndrome<\/strong> \u2014 Caquexia em roedores com tumores, desgaste associado \u00e0 DPOC, modelos de sarcopenia relacionada ao envelhecimento; sinal de apetite menor que o GHRP-6 torna o GHRP-2 \u00fatil quando a ingest\u00e3o de alimentos \u00e9 um fator confundente<\/li>\n<li><strong>Farmacologia do eixo da grelina<\/strong> \u2014 reduced but non-zero appetite signal; useful arm for separating GHS-R-mediated appetite from GH-axis effects<\/li>\n<li><strong>Comparative GHS studies<\/strong> \u2014 Compara\u00e7\u00e3o direta com <a href=\"https:\/\/medsbase.com\/pt-br\/ghrp-6\/\">GHRP-6<\/a> (irm\u00e3o de primeira gera\u00e7\u00e3o), <a href=\"https:\/\/medsbase.com\/pt-br\/ipamorelin\/\">Ipamorelina<\/a> (terceira gera\u00e7\u00e3o seletiva para receptor), hexarelina e pequenas mol\u00e9culas GHS oralmente ativas, como MK-677<\/li>\n<li><strong>Combined GHRP + GHRH use<\/strong> \u2014 canonical &#8220;GHRP-2 + GHRH&#8221; synergistic protocol for maximal GH-pulse support stimulus, pairing GHRP-2 with <a href=\"https:\/\/medsbase.com\/pt-br\/sermorelin\/\">Sermorelina<\/a> ou <a href=\"https:\/\/medsbase.com\/pt-br\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a>.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre onde o GHRP-2 se encaixa no cen\u00e1rio de pept\u00eddeos do eixo do crescimento, consulte <a href=\"https:\/\/medsbase.com\/pt-br\/ghrp-6\/\">GHRP-6<\/a> como o irm\u00e3o de primeira gera\u00e7\u00e3o, <a href=\"https:\/\/medsbase.com\/pt-br\/ipamorelin\/\">Ipamorelina<\/a> como o an\u00e1logo mais novo seletivo para receptor, e <a href=\"https:\/\/medsbase.com\/pt-br\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> como o parceiro sin\u00e9rgico can\u00f4nico GHRH. Navegue pelo <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\">cat\u00e1logo de pept\u00eddeos<\/a> para compostos relacionados. <\/p>\n<h2>Concentra\u00e7\u00f5es e Dosagens Dispon\u00edveis<\/h2>\n<p>MedsBase stocks GHRP-2 Acetate in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosagem do Frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de Uso T\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos de Embalagem<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 short-cycle GH-pulse protocols, single-cohort studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolos de ciclo estendido, estudos de m\u00faltiplas coortes, menor custo por mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized acetate-salt powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols. Because GHRP-2 dose ranges are in the 100\u2013500\u00a0mcg per administration regime, a single 5\u00a0mg vial supports many weeks of use at typical doses. <\/p>\n<h2>Como Comparar \u2014 GHRP-2 vs GHRP-6<\/h2>\n<p>GHRP-2 e <a href=\"https:\/\/medsbase.com\/pt-br\/ghrp-6\/\">GHRP-6<\/a> are the two canonical first-generation hexapeptide growth hormone secretagogues from the Bowers clinical programme. They share the same receptor (GHS-R1a) and the same six-residue hexapeptide architecture, differing primarily in the amino acid at position 2 \u2014 D-2-naphthylalanine in GHRP-2 versus D-tryptophan in GHRP-6. This single substitution accounts for most of the pharmacological differences observed in published studies. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHRP-2 (Pralmorelina)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHRP-6<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">6 amino\u00e1cidos (hexapept\u00eddeo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">6 amino\u00e1cidos (hexapept\u00eddeo)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Res\u00edduo na posi\u00e7\u00e3o 2<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">D-2-naftilalanina (D-2-Nal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">D-triptofano (D-Trp)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Pot\u00eancia por mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2\u20133\u00d7 mais potente<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pot\u00eancia de base de primeira gera\u00e7\u00e3o<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sinal de apetite<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Reduzido (ainda presente, menor que GHRP-6)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte (efeito orexig\u00eanico semelhante \u00e0 grelina)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Cortisol \/ prolactina<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aumentos modestos (compar\u00e1veis ao GHRP-6)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aumentos modestos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meia-vida plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~15\u201320 min<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30\u201360 min<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013500 mcg, 1\u20133x ao dia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013300 mcg, 1\u20133 vezes ao dia<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Teste diagn\u00f3stico para defici\u00eancia de GH (apenas no Jap\u00e3o)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhum aprovado em qualquer lugar<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies where appetite stimulation is part of the target endpoint (cachexia models, food-intake studies), GHRP-6 is the conventional choice because the orexigenic signal is stronger. For studies where the appetite confound is a concern but cortisol\/prolactin tolerability is acceptable, GHRP-2 produces a sharper GH pulse with less feeding-behaviour interference. For the cleanest possible GH-axis pharmacology where cortisol and prolactin must be controlled, <a href=\"https:\/\/medsbase.com\/pt-br\/ipamorelin\/\">Ipamorelina<\/a> (an\u00e1logo seletivo de terceira gera\u00e7\u00e3o) \u00e9 a alternativa seletiva ao receptor. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para estoque de trabalho de curto prazo. Para armazenamento de longo prazo n\u00e3o aberto, congele a \u221220 \u00b0C. O acetato de GHRP-2 liofilizado \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o por at\u00e9 24 meses e a \u221220 \u00b0C por at\u00e9 36 meses. Evite ciclos de congelamento-descongelamento no p\u00f3 liofilizado. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg dose; 0.1\u00a0mL delivers 250\u00a0mcg. Swirl gently \u2014 do <strong>n\u00e3o<\/strong> sacuda \u2014 e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. Uma solu\u00e7\u00e3o reconstitu\u00edda corretamente deve estar l\u00edmpida e incolor. <strong>Ap\u00f3s a reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138 \u00b0C e use dentro de 30 dias para estabilidade ideal. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congelamento-descongelamento degradam a integridade do pept\u00eddeo. Descarte qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is GHRP-2 used for in studies?<\/h3>\n<p>GHRP-2 is used in studies investigating the growth hormone axis, pulsatile GH release dynamics, somatotroph dose-response characterisation, GH-deficiency diagnostic protocols, ghrelin-axis pharmacology, cachexia and wasting syndrome models, and combined GHRP + GHRH synergistic GH-release protocols. It is the most potent first-generation GHS peptide on a per-mg basis. The pharmaceutical-grade GHRP-2 sold here is <strong>n\u00e3o<\/strong> FDA-approved (except for the diagnostic indication in Japan) and is supplied strictly for clinical studies use only. <\/p>\n<h3>Como o GHRP-2 difere do GHRP-6?<\/h3>\n<p>Ambos s\u00e3o secretagogos de horm\u00f4nio do crescimento hexapept\u00eddicos de primeira gera\u00e7\u00e3o que atuam no mesmo receptor GHS-R1a, mas diferem no amino\u00e1cido na posi\u00e7\u00e3o 2 \u2014 D-2-naftilalanina no GHRP-2 versus D-triptofano no GHRP-6. Essa \u00fanica substitui\u00e7\u00e3o torna o GHRP-2 cerca de 2\u20133\u00d7 mais potente por mg e produz um sinal de apetite menor. Ambos os pept\u00eddeos mant\u00eam o modesto sinal de cortisol\/prolactina que os an\u00e1logos seletivos de receptor mais recentes (como o Ipamorelina) foram projetados para eliminar. A meia-vida plasm\u00e1tica \u00e9 mais curta para o GHRP-2 (~15\u201320 min) em compara\u00e7\u00e3o com o GHRP-6 (~30\u201360 min). <\/p>\n<h3>Qual \u00e9 a diferen\u00e7a entre GHRP-2 e Pralmorelina?<\/h3>\n<p>They are the same compound under different names. &#8220;GHRP-2&#8221; is the studies-literature designation; &#8220;Pralmorelin&#8221; is the international nonproprietary name (INN); &#8220;KP-102&#8221; was the original Kaken Pharmaceutical developmental code. The compound was approved in Japan under the Pralmorelin name as a single-use intravenous diagnostic test for adult growth hormone deficiency \u2014 the only Western-style regulatory approval of any GHRP-series peptide to date. <\/p>\n<h3>What is the typical GHRP-2 dose?<\/h3>\n<p>Published preclinical protocols typically use 100\u2013500\u00a0mcg per administration, given subcutaneously 1\u20133 times daily for 2\u201312 week cycles. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 0.04\u00a0mL equals 100\u00a0mcg, 0.1\u00a0mL equals 250\u00a0mcg. The Japanese diagnostic-test dose is 100\u00a0mcg intravenously as a single administration. <\/p>\n<h3>O GHRP-2 \u00e9 aprovado pela FDA?<\/h3>\n<p>No. GHRP-2 is not approved by the FDA, EMA, MHRA, or any other Western regulator for human therapeutic or diagnostic use. It is approved in Japan under the name Pralmorelin Hydrochloride \/ GHRP Kaken as a single-use intravenous diagnostic agent for adult growth hormone deficiency testing. <\/p>\n<h3>Como o GHRP-2 Acetato deve ser armazenado?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para estoque de trabalho em curto prazo, ou \u221220 \u00b0C para armazenamento em longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, usar dentro de 30 dias. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congelamento e descongelamento degradam o pept\u00eddeo. Proteja da luz direta em todos os momentos. <\/p>\n<h3>Como devo reconstituir o GHRP-2?<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o liofilizado), agite suavemente e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> Agite o frasco. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 clara e incolor. Para um frasco de 5 mg + 2,0 mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 2,5 mg\/mL. <\/p>\n<h3>Quais dosagens a MedsBase oferece?<\/h3>\n<p>MedsBase carries GHRP-2 Acetate in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Por que o GHRP-2 \u00e9 mais potente que o GHRP-6?<\/h3>\n<p>The structural difference is the amino acid at position 2 of the hexapeptide \u2014 D-2-naphthylalanine in GHRP-2 versus D-tryptophan in GHRP-6. The naphthyl ring is more lipophilic and slightly larger than the indole ring of tryptophan, producing tighter binding to the hydrophobic pocket of the GHS-R1a receptor. Radioligand-binding assays show approximately 2\u20133-fold higher receptor occupancy at equivalent doses, which translates into a larger GH pulse per unit dose in published preclinical and clinical studies. <\/p>\n<h3>Can GHRP-2 be paired with a GHRH analog in studies?<\/h3>\n<p>Sim \u2014 este \u00e9 o protocolo can\u00f4nico sin\u00e9rgico de pulso de GH e a base do teste diagn\u00f3stico cl\u00ednico japon\u00eas para defici\u00eancia de GH. O GHRP-2 ativa o GHS-R1a (PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> sinaliza\u00e7\u00e3o) enquanto an\u00e1logos de GHRH como <a href=\"https:\/\/medsbase.com\/pt-br\/sermorelin\/\">Sermorelina<\/a> ou <a href=\"https:\/\/medsbase.com\/pt-br\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> ativar o GHRH-R (sinaliza\u00e7\u00e3o da adenilil ciclase\/cAMP\/PKA). As duas vias convergem para os somatotr\u00f3ficos, mas utilizam sistemas de segundos mensageiros diferentes, produzindo libera\u00e7\u00e3o de GH aditiva ou sin\u00e9rgica quando combinadas. <\/p>\n<h3>Does GHRP-2 cause side reported effects?<\/h3>\n<p>The principal on-target effects are GH release and (modest) appetite stimulation. Off-target findings include modest cortisol and prolactin increases \u2014 the principal studies-relevant confound for clean GH-axis studies \u2014 comparable in magnitude to GHRP-6. Transient flushing or local injection-site reactions are reported. At high doses, GHS-R-mediated effects on cardiac function and blood pressure can be observed. The cortisol\/prolactin signal is the main reason newer-generation selective analogs such as Ipamorelin were developed. <\/p>\n<h3>Qual \u00e9 a meia-vida do GHRP-2?<\/h3>\n<p>In preclinical and clinical studies, GHRP-2 has a plasma half-life of approximately 15\u201320 minutes following subcutaneous or intravenous administration \u2014 somewhat shorter than GHRP-6 (~30\u201360 min). The shorter half-life produces a sharper, more reproducible GH pulse that is useful for diagnostic and dose-response studies, but requires more frequent dosing for sustained-stimulus protocols. <\/p>\n<h3>How long does GHRP-2 take to show effects in preclinical studies?<\/h3>\n<p>Pulsos agudos de GH s\u00e3o detect\u00e1veis dentro de 10\u201320 minutos ap\u00f3s administra\u00e7\u00e3o subcut\u00e2nea ou intravenosa e atingem o pico em 30\u201345 minutos \u2014 in\u00edcio mais r\u00e1pido que o GHRP-6 devido \u00e0 maior afinidade pelo GHS-R1a. Os efeitos de estimula\u00e7\u00e3o do apetite sobre a ingest\u00e3o de alimentos s\u00e3o menores e mais lentos para se desenvolverem do que com o GHRP-6. Os efeitos subsequentes na produ\u00e7\u00e3o de IGF-1 e na sinaliza\u00e7\u00e3o do eixo GH em n\u00edvel tecidual se acumulam ao longo de 1\u20134 semanas de dosagem regular. <\/p>\n<h3>Posso pedir GHRP-2 para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia GHRP-2 para todo o mundo a partir de nossa rede dedicada de envio de pept\u00eddeos. Pedidos apenas de pept\u00eddeos se qualificam para nosso servi\u00e7o de envio de pept\u00eddeos independente. Todos os pedidos s\u00e3o enviados em embalagens com controle de temperatura, com rastreamento completo e s\u00e3o cobertos por nossa <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Reenvio Garantido<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Growth-Axis, GH-Release, and Anabolic Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-br\/ghrp-6\/\"><strong>GHRP-6<\/strong><\/a> \u2014 Irm\u00e3o hexapept\u00eddeo de primeira gera\u00e7\u00e3o \u2014 sinal de apetite mais forte, meia-vida mais longa<\/li>\n<li><a href=\"\/pt-br\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Pentapept\u00eddeo GHS seletivo de terceira gera\u00e7\u00e3o \u2014 pulso de GH limpo sem cortisol\/prolactina<\/li>\n<li><a href=\"\/pt-br\/cjc-1295-with-dac\/\"><strong>CJC-1295 com DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH de a\u00e7\u00e3o prolongada \u2014 parceiro sin\u00e9rgico can\u00f4nico de GHRH<\/li>\n<li><a href=\"\/pt-br\/sermorelin\/\"><strong>Sermorelina<\/strong><\/a> \u2014 Shorter-acting GHRH(1-29) analog \u2014 natural GH-pulse support<\/li>\n<li><a href=\"\/pt-br\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 An\u00e1logo recombinante de IGF-1 com arginina longa \u2014 a jusante do eixo GH\/IGF<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore o panorama dos pept\u00eddeos do eixo GH<\/strong><\/p>\n<p style=\"margin: 0;\">Navegue pela categoria completa <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\"><strong>cat\u00e1logo de pept\u00eddeos<\/strong><\/a>, com compostos relacionados ao eixo GH incluindo <a href=\"https:\/\/medsbase.com\/pt-br\/ghrp-6\/\">GHRP-6<\/a> for first-generation sibling studies, <a href=\"https:\/\/medsbase.com\/pt-br\/ipamorelin\/\">Ipamorelina<\/a> for clean receptor-selective GHS studies, and <a href=\"https:\/\/medsbase.com\/pt-br\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> for long-acting GHRH use.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Hexapept\u00eddeo GHS de primeira gera\u00e7\u00e3o mais potente<br \/>\n\u2705 Agonista do receptor GHS-R1a\/ghrelina<br \/>\n\u2705 Pulso de GH mais acentuado que o GHRP-6<br \/>\n\u2705 Sinal de apetite menor que o GHRP-6<br \/>\n\u2705 Aprovado como Pralmorelin no Jap\u00e3o para diagn\u00f3stico de defici\u00eancia de GH<\/p>\n<p><strong>Acetato de GHRP-2<\/strong> cont\u00e9m composto de pept\u00eddeo sint\u00e9tico.<\/p>","protected":false},"featured_media":70954,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6281,6283,5441,6282],"class_list":["post-70740","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-ghrp-2","product_tag-kp-102","product_tag-peptide","product_tag-pralmorelin","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product\/70740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/comments?post=70740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media\/70954"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media?parent=70740"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_brand?post=70740"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_cat?post=70740"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_tag?post=70740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}